Posted inHealth
Novo Nordisk to Cut Ozempic, Wegovy US List Prices Up to 50% in Major GLP-1 Reset
Novo Nordisk is preparing a major change to the U.S. pricing of its best-selling GLP-1 medicines. According to a Wall Street Journal report cited by Reuters, the Danish pharmaceutical company…







